概括
长期用于类风湿性疾病的诺基因治疗可能会导致视网膜变化. 然而,眼部毒性风险是可以接受的低,在大多数患者中观察到最小的视力恶化.
科学领域:
- 眼科医生 眼科 眼科
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氨酸是各种类风湿性疾病的长期治疗方法.
- 长期使用黄素与潜在的眼睛毒性有关,特别是视网膜病变.
- 在接受慢性黄素治疗的患者中,对副作用的监测至关重要.
研究的目的:
- 调查长期使用洛昆治疗的风湿性疾病患者视网膜变化的发生率和特征.
- 评估氨酸剂量,治疗时间,患者年龄和视网膜病变的发展之间的关系.
- 评估视网膜病变的进展及其对视力敏度随时间推移的影响.
主要方法:
- 对222名风湿性疾病患者的眼科数据进行了回顾性分析,这些患者接受了洛昆治疗.
- 视网膜发现与患者年龄,累计克洛洛昆剂量和治疗持续时间的相关性.
- 眼科检查包括视力敏度评估和监测视网膜病变的迹象.
主要成果:
- 在222名接受长期黄素治疗的患者中,有22名 (9.9%) 观察到视网膜变化.
- 视网膜变化的发生与患者的年龄,总克洛洛昆剂量和治疗持续时间显著相关.
- 只有一个患者经历了视网膜病变的进展,视敏度恶化;其他患者保持正常视力.
结论:
- 在患有类风湿性疾病的患者中,黄素相关的视网膜病变似乎相对不常见.
- 由于黄素视网膜病变造成显著视力损伤的风险很低,即使长期使用.
- 与黄素治疗相关的眼部毒性风险通常被认为是可接受的低对于类风湿性疾病的管理.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...